ARTICLE | Company News
Evotec deal
August 15, 2011 7:00 AM UTC
Evotec granted an undisclosed animal health company exclusive, worldwide rights to EVT401 for veterinary uses. EVT401 is a small molecule P2X7 receptor antagonist. Evotec, which retains rights to th...